Patents by Inventor Mark Currie

Mark Currie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8779090
    Abstract: Peptides that act as GC-C receptor agonists and contain at least one D-cys and are useful for the treatment of diuresis and heart disease as well as other disorders are described.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: July 15, 2014
    Assignee: Ironwood Pharmaceuticals, Inc.
    Inventors: Daniel Zimmer, Angelika Fretzen, Mark Currie, G. Todd Milne
  • Patent number: 8273606
    Abstract: The present invention relates to a method of fabricating a semiconductor package or circuit assembly using an fluxing underfill composition applied to solder contact points in a dip process.
    Type: Grant
    Filed: September 17, 2010
    Date of Patent: September 25, 2012
    Assignees: Henkel Corporation, Henkel Ltd
    Inventors: Chew B. Chan, Qing Ji, Mark Currie, Neil Poole, Geraldine Kelly
  • Publication number: 20120040892
    Abstract: Peptides that act as GC-C receptor agonists and contain at least one D-cys and are useful for the treatment of diuresis and heart disease as well as other disorders are described.
    Type: Application
    Filed: February 26, 2008
    Publication date: February 16, 2012
    Inventors: Daniel Zimmer, Angelika Fretzen, Mark Currie, G. Todd Milne
  • Patent number: 8080526
    Abstract: The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: December 20, 2011
    Assignee: Ironwood Pharmaceuticals, Inc.
    Inventors: Mark Currie, Shalina Mahajan-Miklos, G. Todd Milne, Thea Norman
  • Publication number: 20110065242
    Abstract: The present invention relates to a method of fabricating a semiconductor package or circuit assembly using an fluxing underfill composition applied to solder contact points in a dip process.
    Type: Application
    Filed: September 17, 2010
    Publication date: March 17, 2011
    Inventors: Chew B. Chan, Qing Ji, Mark Currie, Neil Poole, Geraldine Kelly
  • Publication number: 20110021419
    Abstract: Peptides that act as GC-C receptor agonists and contain at least one D-cys and are useful for the treatment of diuresis and heart disease as well as other disorders are described.
    Type: Application
    Filed: February 26, 2008
    Publication date: January 27, 2011
    Inventors: Daniel Zimmer, Angelika Fretzen, Mark Currie, G. Todd Milne
  • Patent number: 7850981
    Abstract: Immuno-adjuvant photodynamic therapy to treat and prevent metastatic cancer is effected using photosensitizers in combination with immuno-adjuvants to destroy metastatic tumor cells.
    Type: Grant
    Filed: November 9, 2004
    Date of Patent: December 14, 2010
    Assignees: QLT, Inc., University of British Columbia (UBC)
    Inventors: Patrick Mark Curry, Anna M. Richter, Julia G. Levy, David W. C. Hunt
  • Publication number: 20100257359
    Abstract: A method of providing secure communication over a communication network from a client computer to at least one server computer using a cryptographic security protocol which includes the steps of connecting a secure hardware device to the client computer, and using the device to prevent disclosure on the client computer of login and private information of a user of the client computer.
    Type: Application
    Filed: November 11, 2008
    Publication date: October 7, 2010
    Inventor: Mark Currie
  • Publication number: 20100179235
    Abstract: Disclosed herein are novel compositions for treating or preventing upper GI tract disorders and protecting stratified squamous epithelium against injury by a noxious substance. The pharmaceutical composition comprises at least one bile acid sequestrant, alone or in combination with at least one proton pump inhibitor, and optionally one or more agent chosen from antacids, histamine H2-receptor antagonists, -aminobutyricacid-b (GABA-B) agonists, prodrugs of GABA-B agonists, and protease inhibitors.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 15, 2010
    Applicant: IRONWOOD PHARMACEUTICALS
    Inventor: Mark Currie
  • Publication number: 20100056982
    Abstract: The present method involves the photodynamic treatment of acne vulgaris. The method involves the topical administration of a photosensitizer composition comprising hydrophobic green porphyrins such as lemuteporfin, polyethylene glycol and skin penetration enhancers such as oleyl alcohol and TRANSCUTOLâ„¢ to acne-affected skin and subsequent exposure of that skin to energy of a wavelength of activating the photosensitizer.
    Type: Application
    Filed: February 4, 2005
    Publication date: March 4, 2010
    Applicant: QLT Inc.
    Inventors: Alain H. Curaudeau, Herma C. Neyndorff, Jinj-Song Tao, Morgan Chun Lam, Patrick Mark Curry, Valery Rubinchik, David W.C. Hunt
  • Publication number: 20080096857
    Abstract: The present method involves the photodynamic treatment of hyperactive gland disorders. The method involves the topical administration of a photosensitizer composition comprising hydrophobic and/or lipophilic green porphyrins such as lemuteporfin, polyethylene glycol and skin penetration enhancers such as oleyl alcohol and TRANSCUTOLâ„¢ to affected skin and subsequent exposure of that skin to energy of a wavelength capable of activating the photosensitizer.
    Type: Application
    Filed: February 8, 2005
    Publication date: April 24, 2008
    Applicant: QLT Inc.
    Inventors: Alain H. Curaudeau, Herma C. Neyndorff, Jing-Song Tao, Julia G. Levy, David W.C. Hunt, Morgan Chun Lam, Patrick Mark Curry, Valery Rubinchik
  • Publication number: 20070293542
    Abstract: The invention features compounds that are inhibitors of COX-2 activity. Certain of the compounds are inhibitors of FAAH activity as well as COX-2 activity. The compounds include a 5-membered or 6-membered substituted or unsubstituted heteroaryl or heterocyclyl ring having one or two heteroatoms selected from the group consisting of O, S, and N that is linked to two substituted or unsubstituted 6-membered aryl or heteroaryl groups that can be the same or different.
    Type: Application
    Filed: October 18, 2004
    Publication date: December 20, 2007
    Inventors: Brian Cali, Yueh-Tyng Chien, Mark Currie, John Talley, Craig Zimmerman
  • Publication number: 20070256704
    Abstract: In one aspect, an apparatus is provided that includes (1) an interface adapted to analyze information about an electronic device manufacturing system that produces an effluent having an undesirable material, and provide information about the effluent, and (2) an abatement system adapted to receive information about the effluent, receive the effluent, and attenuate the undesirable material. Numerous other aspects are provided.
    Type: Application
    Filed: March 14, 2007
    Publication date: November 8, 2007
    Inventors: Peter Porshnev, Mark Curry, Sebastien Raoux
  • Publication number: 20070260343
    Abstract: In one aspect of the invention, a method for the improved operation of an electronic device manufacturing system is provided. The method includes providing information to an interface coupled to an electronic device manufacturing system having parameters, processing the information to predict a first parameter, and providing an instruction related to at least a second parameter of the electronic device manufacturing system wherein the instruction is based on the predicted first parameter. Numerous other aspects are provided.
    Type: Application
    Filed: March 14, 2007
    Publication date: November 8, 2007
    Inventors: Sebastien Raoux, Mark Curry, Peter Porshnev, Allen Fox
  • Publication number: 20070249644
    Abstract: Compounds and methods for the treatment of asthma are disclosed. The methods involve mast cell stabilization together with selective inhibition of iNOS. The compounds are combinations of a mast cell inhibiting moiety and an inhibitor of iNOS.
    Type: Application
    Filed: December 23, 2004
    Publication date: October 25, 2007
    Applicant: MICROBIA, INC.
    Inventors: James Pearson, John Talley, Mark Currie
  • Publication number: 20070213943
    Abstract: A system and method for detecting damage to a structure is provided. The system includes a voltage source and at least one capacitor formed as a layer within the structure and responsive to the voltage source. The system also includes at least one sensor responsive to the capacitor to sense a voltage of the capacitor. A controller responsive to the sensor determines if damage to the structure has occurred based on the variance of the voltage of the capacitor from a known reference value. A method for sensing damage to a structure involves providing a plurality of capacitors and a controller, and coupling the capacitors to at least one surface of the structure. A voltage of the capacitors is sensed using the controller, and the controller calculates a change in the voltage of the capacitors. The method can include signaling a display system if a change in the voltage occurs.
    Type: Application
    Filed: February 14, 2006
    Publication date: September 13, 2007
    Inventors: Mark Curry, Simon Senibi, David Banks
  • Publication number: 20070203209
    Abstract: Indoles having various activities, including indoles that are CRTH2 are described. The compounds are useful for treating asthma, neuropathic pain, allegic rhinitis and other disorders.
    Type: Application
    Filed: August 18, 2006
    Publication date: August 30, 2007
    Inventors: Wilmin Bartolini, Brian Cali, Barbara Chen, Yueh-Tyng Chien, Mark Currie, G. Milne, James Pearson, John Talley, Jing Yang, Craig Zimmerman, Alex Monreal
  • Publication number: 20070161698
    Abstract: Modulators of the CRTH2 receptor and their use in the treatment of various disorders, including asthma are described.
    Type: Application
    Filed: March 13, 2007
    Publication date: July 12, 2007
    Inventors: Yueh-Tyng Chien, G. Milne, Mark Currie, John Talley, Brian Cali, Barbara Chen, Craig Zimmerman, Jing Yang
  • Patent number: D1016097
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: February 27, 2024
    Assignee: INGERSOLL-RAND INDUSTRIAL U.S., INC.
    Inventors: Daniel Brocker, Ziv Arzt, James Simmons, Spencer J. Lynn Zeedyk, Allen G. Braggs, Warren A. Seith, Mark Curry, Mark Anthony Ezzo
  • Patent number: D1016856
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: March 5, 2024
    Assignee: INGERSOLL-RAND INDUSTRIAL U.S., INC.
    Inventors: Daniel Brocker, Ziv Arzt, James Simmons, Spencer J. Lynn Zeedyk, Allen G. Braggs, Warren A. Seith, Mark Curry, Mark Anthony Ezzo